Dr. Peter McCullough: COVID-19 pandemic treatment record

Dr. Peter McCullough used an evidence-based early treatment protocol with excellent outcomes. Widespread use of Dr. McCullough's protocol would have ended the pandemic much sooner. See all physicians.
c19early.org
COVID-19 TREATMENT RECORD — Dr. McCullough vs. Dr. Fauci
RECOMMENDED
TREATMENTS
10 of 10
early recommendations
reduce risk
67 - 93% efficacy
$3.65 / treatment
PREDICTED
OUTCOME
1 month
134 deaths
$14 billion
RECOMMENDED
TREATMENTS
0 of 3
early recommendations
reduce risk
-26% efficacy
$4,060 / treatment
ACTUAL
OUTCOME
3 years
20 million deaths
$20 trillion
Dr. Peter McCullough
CENSORED
Dr. Anthony Fauci
10+ AWARDS
$0 $1,000 $2,000+ -25+% 0% 25% 50% Treatment cost (US$) Efficacy vs. cost: Dr. McCullough's protocol vs. USA approved treatments +57 more high-profit drugs PPIs -46% BMS mAbs -36% Darunavir -34% Acetaminophen -28% Cenicriviroc -28% Lufotrelvir Dexamethasone Losartan Sargramostim Cannabidiol Lopinavir/ritonavir Ravulizumab Remdesivir Conv. Plasma Sarilumab Ibuprofen Masks Molnupiravir mutagenic/teratogenic Aspirin Tocilizumab Favipiravir Paxlovid Ratutrelvir Famotidine Vitamin C Sotrovimab Colchicine TMPRSS2 i.. NAC Amubarvimab/r.. Vilobelimab Ensitrelvir Azvudine Budesonide Probiotics HCQ Zinc Antiandro.. Sleep Metformin Vitamin A Melatonin Tixagevimab/c.. Bebtelovimab Nitric Oxide Quercetin H1RAs CPC Vitamin D H. Peroxide Exercise Fluvox. Sunlight Curcumin N. Sativa NaHCO₃ Casirivimab/i.. Bamlanivimab/e.. Ensovibep PVP-I pH+ Diet Regdanvimab Thermotherapy Ivermectin Dr. McCullough US official Lowerrisk Higherrisk c19early.org May 2026 Dr. McCullough's protocol combines low-cost evidence-basedtreatments with complementary and synergistic effects. Efficacyand cost are favorable compared with official treatments.c19early analyzes over 6,600 studies for 221 treatments.
$0 $1,000 $2,000+ -20+% 0% 25% 50% Treatment cost (US$) Efficacy vs. cost: Dr. McCullough's protocol vs. USA approved +57 more high-profit drugs PPIs -46% BMS mAbs -36% Acetaminophen -28% Cenicriviroc -28% Lufotrelvir -22% Dexame.. Losartan Sargramostim CBD Lopinav.. Vit. B9 Ravulizumab Remdesivir C. Plasma Sarilumab Ibuprofen Masks Molnupiravir mutagenic/teratogenic Aspirin Tocilizumab Favipir.. Paxlovid Ratutrelvir Famotidine Vitamin C Sotrovimab Colchicine TMPRSS2 i.. NAC Amubarvimab/r.. Vilobelimab Azvudine Budesonide Probiotics HCQ Zinc Antiandro.. Sleep Metformin Vitamin A Melatonin Tixagev.. Bebtelovimab Nitric Oxide Quercetin H1RAs CPC Vitamin D H. Peroxide Exercise Fluvox. Sunlight Curcumin N. Sativa NaHCO₃ Casirivim.. Bamlan.. Ensovibep PVP-I pH+ Diet Regdanvimab Thermotherapy Ivermectin Dr. McCullough US official Lowerrisk Higherrisk c19early.org May 2026 Dr. McCullough's protocol combineslow-cost evidence-basedtreatments. c19early analyzes over6,600 studies for 221 treatments.
c19early.org
Dr. Peter McCullough's pandemic record—10 out of 10
Dr. McCullough is one of the most cited internists/cardiologists in the world with an h-index of 138 (138 papers receiving 138+ citations each). Dr. McCullough developed an early outpatient multidrug treatment protocol showing very high efficacy. Average treatment cost: $3.65. Predicted combined efficacy: 67%-93%.
CENSORED
Reference Studies Confirmed
beneficial
Outcomes Confidence
HydroxychloroquineHCQ Pathophysiological Basis..Pathophysiol..1 424 March 20202 p < 0.0000001
Vitamin DVitamin D Multifaceted highly targ..Multifaceted..3 137 October 20204 p < 0.0000001
IvermectinIvermectin Multifaceted highly targ..Multifaceted..3 106 August 20205 p < 0.0000001
Vitamin CVitamin C Multifaceted highly targ..Multifaceted..3 72 September 20206 p < 0.0000001
ZincZinc Pathophysiological Basis..Pathophysiol..1 41 July 20207 p = 0.00000012
ColchicineColchicine Pathophysiological Basis..Pathophysiol..1 54 September 20208 p = 0.0000049
QuercetinQuercetin Multifaceted highly targ..Multifaceted..3 9 January 20229 p = 0.0018
FavipiravirFavipiravir Pathophysiological Basis..Pathophysiol..1 74 Positive, small benefit10 p = 0.0096
AspirinAspirin Pathophysiological Basis..Pathophysiol..1 79 Positive, small benefit11 p = 0.015
AzithromycinAzithromycin Pathophysiological Basis..Pathophysiol..1 30 Positive, small benefit12 p = 0.081
References